Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Spyre Therapeutics (SYRE) Q3 2020 Earnings
SYRE
5
Nov
Expected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-16.25
-10.96
-5.68
-0.39
Details
Expected EPS
-0.3917
Actual EPS
-7.25
Surprise EPS
-6.86
Surprise Percent
+1,750.91%
Description
Spyre Therapeutics (SYRE) has reported earnings of -7.25 per share for Q3 2020.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login